- This event has passed.
SPEAKER SERIES: Dr. Sarah Feldstein-Ewing
March 6, 2020 @ 1:00 pm - 2:00 pm PST
Revealing How Adolescents Respond to Addiction Treatment Via the Brain
Sarah Feldstein-Ewing, PhD
Oregon Health and Science University
Many clinicians who provide mental health treatment find developmental neuroscience discoveries to be exciting. However, the utility of these findings often seem far removed from everyday clinical care. Thus, the goal of this presentation is to offer, in the context of adolescent addiction, a bridge to connect the fields of applied adolescent treatment and developmental neuroscience investigation. Concretely, an overview of the relevance of developmental neuroscience in adolescent direct practice is provided. A rationale is offered for how and why the integration of neuroscience into the study of adolescent treatment response could benefit adolescent treatment outcomes. Finally, a series of practical suggestions is generated for improving integration of basic science and psychotherapy research, to enhance collaborative, interdisciplinary work that ultimately advances treatment response for this important clinical population.
Dr. Feldstein Ewing is a Professor of Child and Adolescent Psychiatry, and is serving as the Inaugural Director of Clinical Training (DCT) of the new Clinical Psychology PhD Program at OHSU and Associate Editor at Health Psychology. She has over 15 years of experience utilizing evidence-based approaches to prevent and intervene with adolescent health risk behavior, including substance use. In addition, she has enrolled over 1400 unique youth within her large-scale NIH-funded studies to evaluate the developmental fit and treatment outcomes for motivational interviewing (MI), cognitive behavioral therapy (CBT), behavioral skills training (BST), brief adolescent mindfulness (BAM) and contingency management (CM). With over 100 peer-reviewed publications and 2 edited books, she has published widely regarding the developmental fit, neurocognitive mechanisms, gender differences, and cross-cultural adaptation of treatment approaches for this developmental stage. She has developed a highly-innovative NIH-funded line of translational research evaluating the connection between basic biological mechanisms (e.g., brain structure, function, connectivity) and adolescent health risk behavior (e.g., clinical symptoms, treatment outcomes). She has conducted this work in the contexts of adolescent alcohol use, cannabis use, prescription opioid use, STI/HIV risk, and pediatric overweight/obesity. Dr. Feldstein Ewing has also served as a key member of the National Academy of Sciences Workgroup for the Health Effects of Cannabis (2017), along with additional national and international panels on adolescent substance use and its treatment (e.g., MacArthur Foundation panel on Law and Neuroscience, 2016).
[contact-form to=”firstname.lastname@example.org” subject=”RSVP”][contact-field label=”Name” type=”name” required=”1″][contact-field label=”Email” type=”email” required=”1″][contact-field label=”Department / School” type=”text” required=”1″][contact-field label=”Designation ” type=”checkbox-multiple” required=”1″ options=”Student,Faculty,Staff,Other”][contact-field label=”RSVP ” type=”checkbox” required=”1″][/contact-form]